Senicapoc is a selective androgen receptor modulator under investigation for its potential to address muscle wasting associated with conditions such as cancer cachexia, HIV/AIDS, and chronic obstructive… Read more
Senicapoc is a selective androgen receptor modulator under investigation for its potential to address muscle wasting associated with conditions such as cancer cachexia, HIV/AIDS, and chronic obstructive pulmonary disease. By selectively targeting androgen receptors in skeletal muscle tissue while sparing other androgen-dependent areas, this compound represents a specialized area of pharmacological research. For laboratories engaged in pharmaceutical analysis, our collection of Senicapoc-related compounds provides critical tools for development and quality control. This includes the parent compound as well as stable isotope labelled versions like Senicapoc-d5, which are essential as internal standards for accurate mass spectrometry-based quantification. These high-quality reference standards are vital for impurity profiling, method validation, and ensuring the precision of analytical assays throughout the drug development lifecycle.